Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor...
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib
About this item
Full title
Author / Creator
Publisher
Australia: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Australia: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Summary
Vascular endothelial growth factor inhibitors (VEGFi) are known to cause hypertension and renal injury that severely limits their use as an anticancer therapy. We hypothesized that the angiotensin‐converting enzyme inhibitor captopril not only prevents hypertension, but also decreases renal injury caused by the VEGFi sorafenib.
Rats w...
Alternative Titles
Full title
Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3613249
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3613249
Other Identifiers
ISSN
0305-1870
E-ISSN
1440-1681
DOI
10.1111/j.1440-1681.2012.05699.x
